Department of Medicine Archive — Page 25 of 119
-
March 28, 2024
Study identifies molecule as potential target for treating AML
While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML. -
March 27, 2024
Higher genetic risk of obesity means working out harder for same results
Study authors used activity, clinical and genetic data from the National Institutes of Health’s All of Us Research Program to explore the association of genetic risk of higher body mass index and the level of physical activity needed to reduce incident obesity. -
March 26, 2024
GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes
The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin. -
March 25, 2024
VUMC team finds potential treatment for kidney fibrosis
-
March 18, 2024
Bariatric surgery linked to cardiometabolic health improvements: study
Bariatric surgery can lead to significant cardiometabolic health improvements using a variety of measures, including blood pressure, cholesterol, glucose and hemoglobin A1C, according to a new study published in the Journal of the Endocrine Society. -
March 18, 2024
VUMC’s Sunil Kripalani joins AHRQ Advisory Council
The Agency for Healthcare Research and Quality Council helps guide national priorities for health services research that promotes improvements in the quality, safety and efficiency of clinical practice. -
March 15, 2024
Emerging Infections Program extends, expands disease surveillance research with new grant from the CDC
The Tennessee Emerging Infections Program has been awarded a new five-year grant from the Centers for Disease Control and Prevention to continue infectious disease surveillance research that has been conducted since 1999, and has expanded to include COVID, Mpox and HPV surveillance into oropharyngeal cancers.